18 July 2016

Boots to launch in South Korea

DEERFIELD, Ill., 18 July 2016 – Walgreens Boots Alliance, Inc. (Nasdaq: WBA), the first global pharmacy-led, health and wellbeing enterprise, today announced that it has signed an agreement to form a franchise partnership with Emart Company Ltd (a member of Shinsegae Group), South Korea’s number one hypermarket retailer. Together, they will create a Boots branded pharmacy-led, health and beauty retail franchise in South Korea. 

13 July 2016

Walgreens Boots Alliance Increases Quarterly Dividend

Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that its board of directors has declared a quarterly dividend of 37.5 cents per share, an increase of 4.2 percent.

07 July 2016

Walgreens to Participate in U.S. Precision Medicine Initiative Cohort Program through The Scripps Research Institute

DEERFIELD, Ill., 7 July 2016 – Walgreens, one of the largest drugstore chains in the USA and included in the Retail Pharmacy USA Division of Walgreens Boots Alliance, Inc. (Nasdaq: WBA), will participate in the USA Precision Medicine Initiative (PMI) Cohort Program through an initial $20 million grant awarded to The Scripps Research Institute (TSRI) by the National Institutes of Health (NIH).

06 July 2016

Walgreens Boots Alliance Reports Fiscal 2016 Third Quarter Results

Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced financial results for the third quarter and first nine months of fiscal year 2016 that ended 31 May 2016.

09 June 2016

Walgreens Boots Alliance Announced Changes to Senior Management Team for Next Phase of Evolution

DEERFIELD, Ill., 9 June 2016 - Walgreens Boots Alliance today announced changes to its senior management roles and responsibilities as part of the next phase of evolution. This follows the successful integration of Walgreens and Alliance Boots to create Walgreens Boots Alliance, Inc. (Nasdaq: WBA).

02 June 2016

Walgreens Boots Alliance Schedules Fiscal 2016 Third Quarter Earnings Announcement for 6 July 2016

Walgreens Boots Alliance, Inc. (Nasdaq: WBA) will release its fiscal 2016 third quarter earnings results at 7 a.m. Eastern time Wednesday, 6 July 2016.

26 May 2016

Walgreens Boots Alliance Announces Pricing of $6 Billion of Unsecured, Unsubordinated Notes

DEERFIELD, Ill., 26 May 2016 – Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced the pricing of an underwritten public offering of unsecured, unsubordinated notes.

26 May 2016

Walgreens Boots Alliance, Inc. Rings Nasdaq Opening Bell in Celebration of Red Nose Day

Walgreens Boots Alliance, Inc. (Nasdaq: WBA), the first global pharmacy-led, health and wellbeing enterprise, rang the Opening Bell this morning at the Nasdaq Stock Market in celebration of Walgreens participation in Red Nose Day. Walgreens, one of the nation's largest drugstore chains, is included in the Retail Pharmacy USA Division of Walgreens Boots Alliance.

20 May 2016

Walgreens Boots Alliance’s Board of Directors Thanks JANA Partners’ Barry Rosenstein for Board Service

DEERFIELD, Ill., 20 May 2016 - The board of directors of Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today thanked Barry Rosenstein, managing partner of JANA Partners LLC, for his service as a director of the company (including its predecessor, Walgreen Co.) since September 2014. Pursuant to the Nomination and Support Agreement between Walgreens and JANA signed at that time, Rosenstein’s board service was scheduled to end once JANA reduced its investment in Walgreens below a certain threshold, which JANA did this week. JANA continues to hold a significant stake in Walgreens..

05 May 2016

Walgreens Boots Alliance Announces Secondary Common Stock Offering

DEERFIELD, Ill. (BUSINESS WIRE), May 05, 2016 - Walgreens Boots Alliance, Inc. (Nasdaq: WBA) (the “company”) today announced that affiliates of Kohlberg Kravis Roberts & Co. L.P. (the “selling stockholders”) intend to offer for sale in an underwritten secondary offering 15,000,000 shares of the company’s common stock pursuant to the shelf registration statement (File No. 333-209569) filed by the company with the Securities and Exchange Commission (the “SEC”) on 17 February 2016. The selling stockholders also intend to grant the underwriter a 30-day option to purchase up to an additional 1,500,000 shares of the company's common stock.

You must be logged in to view this item.

This area is reserved for members of the news media. If you qualify, please update your user profile and check the box marked "Check here to register as an accredited member of the news media". Please include any notes in the "Supporting information for media credentials" box. We will notify you of your status via e-mail in one business day.